Pune, India – The biopharmaceutical tubing market is expected to reach $6,013.27 million by 2028 from $3,442.82 million in 2021; it is estimated to grow at a CAGR of 8.3 percent from 2021 to 2028, according to Report Linker. The factors increasing elderly population in world, and rising demand for minimally invasive procedures are contributing to the market growth. However, the stringent regulatory frameworks hinder the biopharmaceutical tubing market growth.
Biopharmaceutical tubing is specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes and peristaltic pumps, as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters and urological retrieval devices.
Rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.
Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal and silicone. In 2020, the silicone segment held the largest share of the market.
Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021–2028.The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing.
In addition to biocompatibility, high temperature and chemical resistance, mechanical strength and electric properties are among the properties that make it a material of choice in biological applications.
Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others.The pharmaceutical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028.
Liquid transfer is an essential part of pharmaceutical manufacturing processes, including the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) such as vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment. Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industries demand ultra-pure and corrosion-resistant systems for liquid transfer that withstand harsh environment of chemicals, which is bolstering the market growth of this segment.
A few major primary and secondary sources referred to while preparing the report on the global biopharmaceutical tubing market are the United States Pharmacopeia (USP), Watson-Marlow Fluid Technology Group (WMFTG), The Italian Institute of Statistics (ISTAT), Asthma and Immunology Society, United Nation’s World Population Ageing 2017 report and US Census Bureau.